Fulbright & Jaworski LLP
Chimeric GB virus B (GBV-B)
The present invention relates generally to the fields of biochemistry, molecular biology, and virology. More particularly, it relates to the identification of GB virus B (GBV-B)/HCV chimeras. The invention involves nucleic acid constructs and compositions encoding GBV-B/HCV chimera, including at least part of a 5′ NTR derived from a HCV 5′ NTR. This construct, and chimeric versions of it, may be employed to study GBV-B and related hepatitis family members, such as hepatitis C virus. The invention thus includes methods of preparing GBV-B/HCV chimeric sequences, constructs, and viruses, as well as methods of employing these compositions.
The Board of Regents of The University of Texas System Institut Pasteur
C C C C C A C G A C C A A A C
C12N C12N C12N C12N C12N A61K C12N G01N A01K C12N C12N A61K A61K A61K C07K
additional additional inventional additional inventional additional additional inventional additional additional additional additional additional additional inventional
David V. Stanley M. Rene Annette
Sangar Lemon Rijnbrand Martin